On April 26, Ge Longhui (300244.SZ) released its report for the first quarter of 2024. Operating income for the reporting period was 2,973 billion yuan, down 8.01% year on year; net profit attributable to shareholders of listed companies was 23.1705 million yuan, down 85.54% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 235.363 million yuan, down 83.01% year on year; basic earnings per share were 0.0371 yuan.
迪安诊断(300244.SZ)：一季度净利润2317.05万元 同比下降85.54%
Dean Diagnosis (300244.SZ): Net profit of 23.1705 million yuan in the first quarter decreased by 85.54% year on year
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.